Murat Akyol

2.3k total citations
87 papers, 1.7k citations indexed

About

Murat Akyol is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Murat Akyol has authored 87 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 24 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Murat Akyol's work include Cancer survivorship and care (11 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Organ Donation and Transplantation (8 papers). Murat Akyol is often cited by papers focused on Cancer survivorship and care (11 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Organ Donation and Transplantation (8 papers). Murat Akyol collaborates with scholars based in Türkiye, United Kingdom and Canada. Murat Akyol's co-authors include John Forsythe, Yüksel Küçükzeybek, Ahmet Alacacıoğlu, Mustafa Oktay Tarhan, İbrahim Vedat Bayoğlu, Lütfiye Demir, Ahmet Dirican, Stephen J. Wigmore, Çiğdem Erten and Yaşar Yıldız and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cell Metabolism.

In The Last Decade

Murat Akyol

76 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murat Akyol Türkiye 19 630 511 375 356 269 87 1.7k
Magnus Rizell Sweden 26 740 1.2× 533 1.0× 783 2.1× 360 1.0× 262 1.0× 92 1.9k
Gagandeep Singh United States 18 641 1.0× 799 1.6× 301 0.8× 325 0.9× 149 0.6× 98 1.5k
Felix Krenzien Germany 21 763 1.2× 518 1.0× 447 1.2× 418 1.2× 50 0.2× 137 1.5k
John B. Ammori United States 22 754 1.2× 681 1.3× 173 0.5× 466 1.3× 98 0.4× 134 1.8k
Simon Harper United Kingdom 23 870 1.4× 201 0.4× 241 0.6× 363 1.0× 405 1.5× 68 1.5k
Kuno Lehmann Switzerland 24 1.2k 1.9× 384 0.8× 433 1.2× 277 0.8× 82 0.3× 66 1.9k
Masayoshi Okumi Japan 26 792 1.3× 441 0.9× 66 0.2× 456 1.3× 246 0.9× 186 2.1k
Jason R. Wellen United States 20 778 1.2× 118 0.2× 411 1.1× 156 0.4× 319 1.2× 60 1.3k
Steven D. Colquhoun United States 24 1.2k 1.9× 307 0.6× 1.3k 3.4× 221 0.6× 257 1.0× 65 2.2k
José Manuel Rodríguez Spain 22 889 1.4× 93 0.2× 161 0.4× 113 0.3× 244 0.9× 109 1.4k

Countries citing papers authored by Murat Akyol

Since Specialization
Citations

This map shows the geographic impact of Murat Akyol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Akyol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Akyol more than expected).

Fields of papers citing papers by Murat Akyol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Akyol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Akyol. The network helps show where Murat Akyol may publish in the future.

Co-authorship network of co-authors of Murat Akyol

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Akyol. A scholar is included among the top collaborators of Murat Akyol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Akyol. Murat Akyol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Akyol, Murat, et al.. (2023). The effect of adjuvant radiotherapy on skin biophysical properties in patients with breast cancer at risk for breast lymphedema: A prospective study. Clinical Physiology and Functional Imaging. 43(4). 263–270. 4 indexed citations
5.
Akyol, Murat, et al.. (2022). The Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma. Molecular Imaging and Radionuclide Therapy. 31(2). 104–113. 3 indexed citations
6.
Akyol, Murat, et al.. (2022). The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC. Nuclear Medicine Communications. 43(12). 1217–1224. 4 indexed citations
7.
Bayoğlu, İbrahim Vedat, Yüksel Küçükzeybek, Ahmet Alacacıoğlu, et al.. (2019). The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer.. PubMed. 22(4). 947–952. 1 indexed citations
8.
Koçoğlu, Hakan, Halil Kavgacı, Meral Günaldı, et al.. (2018). The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis. Journal of Cancer Research and Therapeutics. 14(10). 583–583. 13 indexed citations
9.
Yıldız, Yaşar, Murat Akyol, Ahmet Alacacıoğlu, et al.. (2016). Sexual satisfaction, anxiety, depression and quality of life amoung Turkish gynecological cancer patients. Annals of Oncology. 27. vi306–vi306. 4 indexed citations
10.
Emren, Sadık Volkan, Yaşar Yıldız, Ahmet Alacacıoğlu, et al.. (2015). Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography. Medical Ultrasonography. 17(4). 496–502. 5 indexed citations
11.
Akyol, Murat, Leyla Demir, Ahmet Alacacıoğlu, et al.. (2015). 1953 The effects of adjuvant endocrine treatment on the serum leptin, adiponectin and body composition in patients with breast cancer [Izmir Oncology Group(IZOG) Study]. European Journal of Cancer. 51. S317–S317. 1 indexed citations
12.
Can, Alper, Ahmet Alacacıoğlu, Yüksel Küçükzeybek, et al.. (2014). The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.. PubMed. 18(4). 845–50. 6 indexed citations
13.
Alacacıoğlu, Ahmet, Umut Varol, Tuğba Yavuzşen, et al.. (2014). Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Medical Oncology. 31(7). 43–43. 19 indexed citations
14.
Erten, Çiğdem, Lütfiye Demir, Işıl Somali, et al.. (2013). Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases: a Preferential Option for Triple Negative Patients?. Asian Pacific Journal of Cancer Prevention. 14(6). 3711–3717. 25 indexed citations
15.
Dirican, Ahmet, Yüksel Küçükzeybek, Çiğdem Erten, et al.. (2013). Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma: Second Line Sunitinib Treatment Following IFN-alpha. Asian Pacific Journal of Cancer Prevention. 14(3). 2101–2105. 26 indexed citations
16.
Kefeli, Umut, Murat Akyol, Ramazan Yıldız, et al.. (2013). Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.. PubMed. 60(124). 647–52. 4 indexed citations
17.
Demir, Lütfiye, Neşe Ekinci, Çiğdem Erten, et al.. (2013). Does Immunohistochemistry Provide Additional Prognostic Data in Gastrointestinal Stromal Tumors?. Asian Pacific Journal of Cancer Prevention. 14(8). 4751–4758. 15 indexed citations
18.
Çokmert, Suna, Lütfiye Demir, Ayşegül Sarı, et al.. (2013). Synchronous Appearance of a High-Grade Neuroendocrine Carcinoma of the Ampulla Vater and Sigmoid Colon Adenocarcinoma. SHILAP Revista de lepidopterología. 2013. 1–4. 11 indexed citations
19.
Tarhan, Mustafa Oktay, Lütfiye Demir, Işıl Somali, et al.. (2012). The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival. Clinical & Experimental Metastasis. 30(2). 201–213. 19 indexed citations
20.
Swaminathan, Krishnan, E. Duvall, & Murat Akyol. (2010). When numbers do not add up!. QJM. 104(11). 981–982. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magnus Rizell Breakdown of academic impact, for papers by Gagandeep Singh Breakdown of academic impact, for papers by Felix Krenzien Breakdown of academic impact, for papers by John B. Ammori Breakdown of academic impact, for papers by Simon Harper Breakdown of academic impact, for papers by Kuno Lehmann Breakdown of academic impact, for papers by Masayoshi Okumi Breakdown of academic impact, for papers by Jason R. Wellen Breakdown of academic impact, for papers by Steven D. Colquhoun Breakdown of academic impact, for papers by José Manuel Rodríguez
Rankless by CCL
2026